Pretreatment Out-of-Pocket Expenses for Presumptive Multidrug-Resistant Tuberculosis Patients, India, 2016-2017

In India, under the National Tuberculosis Elimination Programme, the government provides free treatment for multidrug-resistant tuberculosis; however, many patients seek care elsewhere, which is costly. To determine those out-of-pocket expenses, we interviewed 40 presumptive patients and found that...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Emerging infectious diseases 2020-05, Vol.26 (5), p.989-992
Hauptverfasser:	Rathi, Priya, Shringarpure, Kalpita, Unnikrishnan, Bhaskaran, Chadha, Vineet Kumar, Acharya, Vishak, Nair, Abirami, Sagili, Karuna D, Shastri, Suresh
Format:	Artikel
Sprache:	eng
Schlagworte:	Antitubercular Agents - therapeutic use Costs direct cost Disease Disease eradication Dispatch Drug resistance Economic aspects Ethics Family income Health Expenditures Health services Humans Income India - epidemiology indirect cost MDR TB Microbial drug resistance Multidrug resistant organisms Multidrug-resistant tuberculosis Mycobacterium tuberculosis Patients presumptive MDR TB Pretreatment Out-of-Pocket Expenses for Presumptive Multidrug-Resistant Tuberculosis Patients, India, 2016–2017 School dropouts Tuberculosis Tuberculosis - drug therapy tuberculosis and other mycobacteria Tuberculosis, Multidrug-Resistant - drug therapy Tuberculosis, Multidrug-Resistant - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	In India, under the National Tuberculosis Elimination Programme, the government provides free treatment for multidrug-resistant tuberculosis; however, many patients seek care elsewhere, which is costly. To determine those out-of-pocket expenses, we interviewed 40 presumptive patients and found that they spent more than their median annual income before registering for the government program.
ISSN:	1080-6040 1080-6059
DOI:	10.3201/eid2605.181992